Sinemet: Restoring Motor Control in Parkinson's Disease
| Product dosage: 110mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.04 | $62.21 (0%) | 🛒 Add to cart |
| 90 | $0.96 | $93.31 $86.29 (8%) | 🛒 Add to cart |
| 120 | $0.92 | $124.41 $110.37 (11%) | 🛒 Add to cart |
| 180 | $0.88 | $186.62 $157.52 (16%) | 🛒 Add to cart |
| 270 | $0.85 | $279.93 $230.77 (18%) | 🛒 Add to cart |
| 360 | $0.83
Best per pill | $373.24 $300.00 (20%) | 🛒 Add to cart |
| Product dosage: 125mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.54 | $46.15 (0%) | 🛒 Add to cart |
| 60 | $1.30 | $92.31 $78.26 (15%) | 🛒 Add to cart |
| 90 | $1.22 | $138.46 $109.36 (21%) | 🛒 Add to cart |
| 120 | $1.17 | $184.61 $140.47 (24%) | 🛒 Add to cart |
| 180 | $1.13 | $276.92 $203.68 (26%) | 🛒 Add to cart |
| 270 | $1.10 | $415.38 $297.99 (28%) | 🛒 Add to cart |
| 360 | $1.09
Best per pill | $553.84 $393.31 (29%) | 🛒 Add to cart |
| Product dosage: 275mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.44 | $73.24 (0%) | 🛒 Add to cart |
| 60 | $2.06 | $146.49 $123.41 (16%) | 🛒 Add to cart |
| 90 | $1.93 | $219.73 $173.58 (21%) | 🛒 Add to cart |
| 120 | $1.86 | $292.97 $223.74 (24%) | 🛒 Add to cart |
| 180 | $1.79 | $439.46 $323.07 (26%) | 🛒 Add to cart |
| 270 | $1.76 | $659.19 $474.58 (28%) | 🛒 Add to cart |
| 360 | $1.74
Best per pill | $878.92 $625.07 (29%) | 🛒 Add to cart |
Synonyms
| |||
Sinemet is a cornerstone pharmaceutical therapy specifically formulated for the management of Parkinson’s disease and parkinsonism. It combines two active ingredients, carbidopa and levodopa, to effectively replenish dopamine levels in the brain, addressing the fundamental neurotransmitter deficiency responsible for the motor symptoms of the condition. This medication is designed to significantly improve quality of life by restoring functional mobility and reducing disability.
Features
- A precise combination of carbidopa and levodopa in immediate-release and controlled-release tablet formulations.
- Available in multiple strength ratios (e.g., 10/100, 25/100, 25/250) to allow for individualized titration.
- Carbidopa component inhibits peripheral decarboxylation of levodopa, allowing a greater proportion to cross the blood-brain barrier.
- Manufactured under strict pharmaceutical quality control standards to ensure consistent dosing and bioavailability.
Benefits
- Significant Improvement in Motor Symptoms: Effectively reduces tremor, rigidity, bradykinesia (slowness of movement), and postural instability.
- Enhanced Functional Capacity: Enables patients to perform daily living activities with greater ease and independence.
- Smoother Symptom Control: The carbidopa component minimizes peripheral side effects like nausea, allowing for better tolerability and higher effective doses of levodopa.
- Proven Long-Term Efficacy: Decades of clinical use and research support its role as a first-line therapy for managing Parkinsonian symptoms.
- Flexible Dosing Regimens: Multiple available strengths facilitate precise dose adjustment to meet the evolving needs of the patient throughout the disease course.
Common use
Sinemet is primarily indicated for the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication or manganese intoxication. It is not indicated for the treatment of drug-induced extrapyramidal reactions.
Dosage and direction
Dosage is highly individualized and must be titrated according to the patient’s response. Therapy is typically initiated with a low dose, such as one tablet of Sinemet 25/100 (containing 25 mg carbidopa and 100 mg levodopa) taken three times daily. The dose may be increased by one tablet every day or every other day until a maximum therapeutic response is achieved. The frequency of dosing usually ranges from three to four times daily, though some patients with advanced disease and motor complications may require more frequent administration. Tablets should be swallowed whole with water and can be taken with or without food, though a protein-rich meal may interfere with absorption. The controlled-release formulation (Sinemet CR) is typically administered on a less frequent schedule, often twice daily.
Precautions
- Patients should be monitored for the development of depression with concomitant suicidal tendencies.
- Use with caution in patients with severe cardiovascular or pulmonary disease, bronchial asthma, renal, hepatic, or endocrine disease.
- May cause dizziness or orthostatic hypotension; caution patients against rising rapidly from a sitting or lying position.
- Can cause drowsiness and somnolence; advise patients about the potential of falling asleep during activities of daily living, including operating machinery or driving.
- May elevate blood urea nitrogen, creatinine, uric acid, and transaminases.
- Periodic evaluations of hepatic, hematopoietic, cardiovascular, and renal function are recommended during extended therapy.
- Not recommended for patients under 18 years of age.
Contraindications
- Hypersensitivity to any component of this medication.
- Concomitant use with nonselective monoamine oxidase (MAO) inhibitors or within 2 weeks of discontinuing them. MAO-B inhibitors (e.g., rasagiline, selegiline) may be used with caution.
- Patients with narrow-angle glaucoma.
- Patients with a history of melanoma or with undiagnosed skin lesions.
Possible side effect
Common side effects may include: nausea, vomiting, dizziness, orthostatic hypotension, arrhythmias, choreiform, dystonic, and other abnormal involuntary movements. Psychiatric disturbances such as agitation, anxiety, confusion, depression, hallucinations, and paranoid ideation can occur. Other effects include dry mouth, dysphagia, darkening of sweat and urine, and on-off phenomena.
Drug interaction
- Antihypertensive Drugs: May produce orthostatic hypotension, requiring dosage adjustment of the antihypertensive agent.
- Phenothiazines and Butyrophenones: These antipsychotic drugs can reduce the therapeutic effects of Sinemet.
- Tricyclic Antidepressants: May reduce the absorption of levodopa and increase the risk of hypertension and dyskinesia.
- MAO Inhibitors: Contraindicated due to risk of hypertensive crisis.
- Dopamine D2 Receptor Antagonists (e.g., metoclopramide, risperidone): May diminish the effectiveness of Sinemet.
- Anticholinergics: May enhance the therapeutic effects of levodopa but also increase the risk of adverse effects.
- Protein-rich meals: Can interfere with the gastrointestinal absorption of levodopa.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not double the next dose to make up for the missed one, as this increases the risk of side effects.
Overdose
Symptoms of overdose are primarily related to the levodopa component and may include severe nausea and vomiting, profound hypotension, cardiac arrhythmias, and intense abnormal involuntary movements. Mental disturbances including confusion, insomnia, and agitation are common. In severe cases, psychosis may occur. Management is primarily symptomatic and supportive. Pyridoxine (Vitamin B6) is NOT effective in reversing the effects of overdose of Sinemet due to the presence of the decarboxylase inhibitor carbidopa. Gastric lavage may be considered with appropriate airway protection. ECG monitoring is recommended.
Storage
Store at room temperature between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F). Keep the container tightly closed to protect from moisture and light. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“Sinemet remains the gold standard for symptomatic control of Parkinson’s disease in my neurology practice. While side effects and long-term complications like dyskinesias are a challenge, its efficacy in restoring motor function is unparalleled for the majority of patients.” - Neurologist, 15 years of experience.
“The introduction of Sinemet for my patient was transformative. We successfully titrated the dose over several weeks, resulting in a marked reduction in his resting tremor and rigidity. His ability to walk and perform self-care tasks improved dramatically.” - Movement Disorder Specialist.
“Managing the ‘wearing-off’ effect in long-term users requires careful dose timing and sometimes adjunct therapies, but Sinemet continues to be the foundational agent upon which we build an effective treatment regimen.” - Clinical Pharmacist specializing in neurology.